LakeShore Biopharma Initiates Biologics License Application Of PIKA Rabies Vaccine To The Drug Regulatory Authority Of Pakistan

Benzinga11/07 21:12

Lacklustre Performance Is Driving LakeShore Biopharma Co., Ltd's (NASDAQ:LSB) 66% Price Drop

Simply Wall St11/01 21:40

LakeShore Biopharma Regains Compliance With Nasdaq Minimum Bid Price Requirement

PRNewswire10/29 20:30

LakeShore Biopharma Receives Phase III Trial Approval In China For Simplified Four-Dose YSJA Rabies Vaccine Regimen; Aims To Enhance Patient Adherence And Reduce Costs While Maintaining Immunogenicity

Benzinga10/25 20:34

LakeShore Biopharma Shares Higher on Unchanged FY Guidance

WSJ10/09 01:58

LakeShore Biopharma Sees Prelim. 1H Revenue RMB350M-RMB380M, Representing 28-39% Growth

Benzinga10/08 20:34